Stockscreener 앱 받기
3.72
0.54%
0.02
전일 마감가:
$3.70
열려 있는:
$3.75
하루 거래량:
28,114
Relative Volume:
0.49
시가총액:
$125.77M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-21.85%
1개월 성능:
-48.48%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$3.69
$4.09
1주일 범위
$3.51
$4.76
52주 변동 폭
$3.51
$21.00
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
명칭
Neonc Technologies Holdings Inc
전화
310 663 7831
주소
23975 PARK SORRENTO, CALABASAS
NTHI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
3.72 | 125.77M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.82 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
520.29 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
321.94 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.53 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
267.12 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Neonc Technologies Holdings Inc 주식(NTHI)의 최신 뉴스
NeOnc Technologies Appoints Dr. Josh Neman as CCO - TipRanks
NeOnc Technologies files to sell 10.02M shares of common stock by selling shareholders - MSN
NeOnc Technologies Files Prospectus for Resale of Shares - marketscreener.com
NeOnc Technologies appoints new chief clinical officer By Investing.com - Investing.com Nigeria
NeOnc Technologies Appoints New Chief Clinical Officer - TipRanks
NeOnc Technologies Holdings Appoints Dr. Josh Neman as Chief Clinical Officer - citybiz
NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs - The Manila Times
NeOnc Technologies Appoints Dr. Josh Neman as Chief Clinical Officer to Enhance Brain Tumor Treatment and Accelerate Clinical Trials - Nasdaq
NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman - GlobeNewswire
NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance ... - Bluefield Daily Telegraph
Neonc technologies CFO Garnett Keithly sells $164,425 in stock By Investing.com - Investing.com South Africa
Neonc technologies CFO Garnett Keithly sells $164,425 in stock - Investing.com India
'New Frontiers' Presents 4 Companies Revolutionizing: Brian CancNORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
"New Frontiers" Presents Featuring Athena Clinic, MonDak Portables, LLC, NeOnc Technologies Holdings, Inc. & Hollobus Technologies. The content in the episode is a Planet TV Studios Original & it is brought to you by & sponsored by Planet TV Studios. - Kalkine Media
Neonc technologies CFO Garnett Keithly acquires $976 in shares By Investing.com - Investing.com South Africa
Neonc technologies CFO Garnett Keithly acquires $976 in shares - Investing.com Australia
Major Stock Acquisition by NeOnc Technologies’ President! - TipRanks
NeOnc Technologies Appoints New President Amid Strategic Moves - MSN
Clinical Trial of NEO100 Recruiting Patients With Malignant Gliomas - Curetoday
NeOnc Technologies announces global patent portfolio totals 176 - TipRanks
NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical Markets - The Manila Times
NeOnc Technologies Global Patent Portfolio Covers Core Pipeline Across All Major Pharmaceutical - Bluefield Daily Telegraph
NeOnc Sees Share Price Fall Since Going Public - Los Angeles Business Journal
NeOnc Technologies expects full enrollment in Phase 2a trial of NEO100-01 - TipRanks
NeOnc Technologies Expects Full Enrollment in Phase 2a Trialfor NEO100-01 by September - marketscreener.com
Neonc Technologies Holdings Expects Full Enrollment In Promising Phase 2A Trial Of Neo100-01 For Malignant Gliomas In September - MarketScreener
NeOnc Technologies Holdings, Inc. Expects Full Enrollment in Promising Phase 2a Trial of NEO100-01 for Malignant Gliomas in September - The Manila Times
Planet TV Studios Airing “New Frontiers” Episode on NeOnc Technologies Holdings, Inc. – Saturday, April 26th, - EIN News
New CEOs at Alterome, Valo and Imbria - BioCentury
NeOnc Technologies Appoints Executive Chairman Amir Heshmatpour as President - MarketScreener
NeOnc Technologies Holdings, Inc. Executive Chairman, Amir - GlobeNewswire
Germany's economy is expected to stagnate at best this year - The Globe and Mail
2 Reasons Nu Holdings Stock Is a Buy Before May 13 - The Globe and Mail
Rigetti Computing Stock (RGTI) Surges 21% as Market Optimism Returns - The Globe and Mail
NeOnc Technologies Phase 1 Trial Enrollment for NEO212 Brain Cancer Drug Nears Full Enrollment - MarketScreener
NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy - GlobeNewswire
Dow Jones Index Daily Report: DIA Rebounds Today After Tariff Tantrum - The Globe and Mail
Nvidia Stock (NVDA) Smashes Back as AI Demand Counters Tariff Panic - The Globe and Mail
NeOnc Technologies Partners with CBCC for Clinical Expansion - TipRanks
Neonc Technologies appoints new accounting firm By Investing.com - Investing.com Canada
Neonc Technologies appoints new accounting firm - Investing.com India
NeOnc Technologies receives RPDD for NEO100 - TipRanks
NeOnc Technologies Holdings: New IPO gets a Rare Pediatric Disease Designation and a 37.92% Jump in the Market - RagingBull
NeOnc Technologies Holdings' Perillyl Alcohol Receives FDA's Rare Pediatric Disease Designation - MarketScreener
NeOnc Falls Despite FDA Nod - Baystreet.ca
NeOnc Technologies Holdings, Inc. Receives Rare Pediatric - GlobeNewswire
Robinhood, Couchbase And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas - Yahoo Finance
Neonc Technologies Holdings Inc (NTHI) 재무 분석
Neonc Technologies Holdings Inc (NTHI)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Neonc Technologies Holdings Inc 주식 (NTHI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| CHEN THOMAS C | CEO |
May 21 '25 |
Buy |
7.25 |
2,759 |
20,002 |
548,959 |
| CHEN THOMAS C | CEO |
May 22 '25 |
Buy |
7.38 |
2,709 |
20,000 |
551,668 |
| GARNETT KEITHLY | CFO |
May 22 '25 |
Buy |
7.29 |
675 |
4,921 |
240,900 |
| GARNETT KEITHLY | CFO |
May 19 '25 |
Buy |
7.23 |
135 |
976 |
240,225 |
| Delshad Jim | Director |
May 12 '25 |
Buy |
7.22 |
5,000 |
36,110 |
55,310 |
| Delshad Jim | Director |
Mar 26 '25 |
Buy |
16.05 |
50 |
802 |
50,260 |
| Delshad Jim | Director |
Apr 17 '25 |
Buy |
6.92 |
50 |
346 |
50,310 |
| CHEN THOMAS C | CEO |
May 12 '25 |
Buy |
7.00 |
400 |
2,800 |
546,200 |
| Heshmatpour Amir F | President |
May 16 '25 |
Buy |
16.87 |
3,510 |
59,221 |
1,760,000 |
| Heshmatpour Amir F | President |
May 11 '25 |
Buy |
7.51 |
1,600 |
12,016 |
1,751,600 |
1.06%
1.67%
자본화:
|
볼륨(24시간):